Merck abandons £150m Mace-built labs in latest blow to life sciences sector
Digital Edition: Merck abandons £150m Mace-built labs in latest blow to life sciences sector
US drugmaker Merck has scrapped plans to occupy a 10-storey life sciences building in King’s Cross that is currently being built by Mace. Merck’s subsidiary MSD UK was set to be headquartered in the £150m Belgrove House building, which topped out earlier this summer after…

Welcome! To continue reading either:
Access your account
Log in to your account to access your content on Construction News.
Get unlimited access
Subscribe today to ensure you keep up to date with the latest client and contractor news, and interviews with industry leaders.
Premium subscribers gain access to dynamic data dashboards covering material prices, workforce trends, construction activity, and top contractor statistics (turnover, cash flow, and employee count).
Start a FREE trial
Get limited access for 2 weeks. No further commitment, no payment details required.
Access to Premium content not included in trial.
Check if you already have access from your company or university